Tirzepatide
built for her biology
Tirzepatide is a dual GLP-1 and GIP receptor agonist for weight management, prescribed by a licensed provider following an online consultation. Once-weekly subcutaneous injection. Available through MADRES membership.
MADRES tirzepatide is compounded. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. A licensed physician determines whether treatment is appropriate for you. Individual results vary.
Getting started is simpler
than you think.
We connect you with board-certified providers, personalized protocols, and discreet delivery all from your phone.
Tell Us About You
Complete a short health assessment, your symptoms, your history, your goals. No waiting rooms. No judgment. Just the information your provider needs to actually help you.
Meet Your Provider
A board-certified physician reviews your assessment and builds a protocol designed specifically for your body, not a generic plan. Real expertise. Real results.
Receive & Begin
Your medication ships directly and discreetly to your door, typically within 2–10 business days. Your MADRES provider stays with you every step of the way.
Weight loss that finally makes biological sense
The protocol at a glance
Tell us where you are.
Tell us about where you are & we'll see if MADRES is a good fit to help you get where you want to be.
Begin →Confidential · Not a medical evaluation · No commitment required
Your health is a hormone story. Let's rewrite it.
Tirzepatide is a dual GLP-1 and GIP receptor agonist for weight management, prescribed by a licensed provider following an online consultation. Once-weekly s...